In this episode, we are joined by Dr. Jonathan Kaplan, MD, a board-certified plastic surgeon and CEO of BuildMyHealth. Tune in as we unravel compounding Semaglutide – the ingredient in popular weight loss drugs Ozempic and Wegovy. Dr. Kaplan breaks down how Semaglutide works and why it is effective for weight loss. Join us for insights into Semaglutide and the opportunity compounding pharmacies have when a drug is added to the FDA shortage list.

Want to learn more? Check out these article by Dr. Kaplan: 1) https://www.pacificheightsplasticsurgery.com/new-and-improved-weight-management-program/, 2) https://www.pacificheightsplasticsurgery.com/ozempic-and-wegovy-for-weight-loss-qa/

Visit our website www.byrdadatto.com to learn more and to subscribe to the ByrdAdatto newsletter. Follow us on social media to stay up-to-date on the ByrdAdatto family. Finally, subscribe to our YouTube channel for short videos on breaking developments and interesting business and health care compliance topics.

Facebook: https://www.facebook.com/ByrdAdatto/

Twitter: https://twitter.com/ByrdAdatto

Instagram: https://www.instagram.com/byrdadattolaw/

LinkedIn: https://www.linkedin.com/company/byrdadatto

YouTube: https://www.youtube.com/channel/UC6VSOw0W5lrrj4iIl1HxTbg

Fake or Real: It is Legal to Compound Semaglutide, with Jonathan Kaplan, MD